Clear The Air News Tobacco Blog Rotating Header Image

Nicotine Addiction

Could nearly all E-Cigarettes disappear?

http://www.bocaratontribune.com/bocaratonnews/2015/08/could-nearly-all-e-cigarettes-disappear-fda-regulations-to-dramatically-change-the-face-of-vaping-forever/

Could nearly all E-Cigarettes disappear? – FDA Regulations to dramatically change the face of vaping forever

E Cigarettes are electronic devices which allow a user to inhale liquid nicotine, generally flavored, which can contribute to helping a user wean themselves off cigarettes. But is this all good news?

Could E-Cigs be spawning a new health damaging habit?

E-Cigs have yet to be fully studied. Therefore customers are not fully aware of:

Potential risks of E-Cigs.

If there are any benefits associated with using vaping products.

How much nicotine or chemicals are being inhaled while using these products.

If E-Cigarettes influence young people to try tobacco products, which they would have not otherwise have tried. We already know the risks of regular cigarettes. Do we want to potentially influence the next generation to get addicted to something which could lead to regular smoking?

Evidence so far suggests that e cigarettes on the whole are a great idea and the health risks are massively reduced in comparison to regular smoking. But how is the FDA (Food and Drug Administration) going to influence the massive up trend of vaping? E-Cigarettes are facing a possible rapid decline due to upcoming FDA regulations. Mainly they will affect how the products are sold, and what hoops the e cig and e liquid vendors have to jump through. The effects could be catastrophic for the industry. Here are some of the guidelines that could come into place:

Only market new products after FDA review

Vendors and manufacturers to register with FDA and report product and ingredient list

Only make direct claims of health benefits over regular smoking if the FDA confirms the scientific evidence that it will be beneficial to public health overall

No distribution of free samples

Minimum age requirements to stop sale of products to minors

Requirement to show health warnings

No vending machine sales (apart from maybe casinos etc)

Complete overhaul of the way the eliquid is sold – maximum nicotine per ml and maximum sizes making some current products completely obsolete

This might not seem so damaging, but lets take for example the many small vaping shops which have popped up everywhere. In the UK and America, over the last 5 years there has been thousands of small businesses investing into this and opening shops, will they cope with the new regulations?

Effect on small Vaping businesses

Lets take your local vaping shop as an example. Due to new regulation, they will need to get packaging for all their products, and get each tested. They currently generally have a generic packaging for their eliquid, and don’t have to get it tested.

Currently they sell 6mg, 12mg, 18mg & 24mg nicotine strength eliquid. They sell this in a normal PG/VG (propylene glycol and vegetable glycerin) and they generally sell one with a higher VG ratio, this is due to the users preference. They also have 180 flavors.

180 flavours x 4 strengths x 2 types = 1440 different packaging requirements. Can you imagine your local e cig vendor being able to produce that many different types of packaging, and store them? They could possibly get away with having only one box for eliquid per flavor and list the difference in nicotine, but even then the ingredient list may not be accurate enough for the FDA.

Further to this, they will now need to retrospectively apply for each product to be approved. The cost for this is said to run into the millions. We are not sure about the implied cost associated with this, but the New York Times have estimated a pre-market review demonstrating each specific product to be beneficial to smokers and how it would affect non-smokers to cost around $300,000.

There are also many other minor problems vendors will have to deal with. Such as the fact the Eliquid can only be sold in 10ml bottles. So the current 30ml bottles sold, will now be obsolete. On the tech side of things, the batteries and products are going to be regulated to only a few devices, possibly spawning more mass producing of smaller “cigalike” devices – generally the only ones you see on TV advertising at the moment, such as the Vype advertisements. Advertising is likely to take a huge hit as well. There will be no advertising until they can convince the FDA otherwise.

The final word

It seems to us, the astronomical costs of getting Ecigs and Eliquid to market, will not be something which is achievable for a small e cig vendor. That would mean closure of up to 99% of e cigarette businesses. However is this an opportunity for larger companies to absolutely dominate the market? Example being BAT (British American Tobacco). They own Vype, and according to wikipedia, BAT have an annual Revenue of $42 billion, compared to your average ecigarette shop having an annual revenue of around $108,000. Seems to us its a perfect opening for a company with an unlimited budget, it would also be fair to say BAT were all for FDA regulations before they released their own brand of Ecigs. Now they have done a total 180 and consider the FDA to be hindering them, they are calling for the FDA to revisit the proposed guidelines. Despite all this, it would seem it is not deterring some vendors from coming up with new products, VG E Liquid from the UK by Pure E Liquids for example. However it seems this particular brand is ahead of the game in some respects. They already get their eliquid batch tested, so that will make the changeover easier and do not sell anything larger than 10ml. They seem to be preparing for the guidelines as best they can – but will it be enough? With 135,000 comments being reviewed by the FDA though, it doesn’t look like we are facing a British American Tobacco domination, or a catastrophic decline in our local ecig vendors, just yet.

Your Body Immediately After Vaping an E-Cigarette

While much research has been done on conventional cigarettes, data on e-cigs is much more sparse. This is because e-cigs were only invented in 2003 by a Chinese pharmacist, while tobacco has been around for centuries.

Because of e-cigarettes’ relative newness, their potential risks or benefits are not well-understood. There aren’t decades-long epidemiological data for researchers to analyze. Even the U.S. Food and Drug Administration says it’s unclear whether e-cig users are inhaling potentially harmful chemicals. The California Department of Health earlier this year declared them a public health threat.

The general consensus is that e-cigs are less harmful than conventional cigarettes, mainly because there is no smoke or burning involved. “They’re simpler than cigarettes,” Jonathan Foulds, PhD, professor of public health sciences and psychiatry at Penn State University’s College of Medicine and Cancer Institute, tells Yahoo Health. “You burn it, cigarettes creates 7,000 different chemicals into your body. But with e-cigarettes, there’s no combustion. The good news is that you’re inhaling a vapor that’s got four to five things as opposed to 7,000 things.”

But not all e-cigs are created equal. There are hundreds of brands with simple products resembling conventional tobacco cigarettes to more high-end, sophisticated vape pens. The FDA has found inconsistencies with some e-cigs containing nicotine when they’re marketed as free of the substance, not to mention varying levels of quality. At this point, e-cigarettes are not regulated by the FDA, although the agency seeks to change that soon.

Not all e-cigarettes contain nicotine. And some of the products let users control the amount and potency of the liquid solution. What’s inside the liquid solution vary by brand and flavors, such as butter popcorn and cookies and cream, which carry different chemical agents. Other e-cigs are more straightforward, with about five ingredients.

“The question is: What’s the effect on the body of the four to five things?” says Foulds.

The problem remains: lack of data. “There’ve been few studies that investigated the extent of biological effects,” says Jake McDonald, PhD, director of Environmental Respiratory Health Program and the Chemistry and Inhalation Exposure Program at Lovelace Respiratory Research Institute in New Mexico.

So here’s what we know so far about how e-cigarettes may affect your body:

image002

Mouth

Users have complained of cotton mouth, scratchy throat, and coughing. It’s unclear why this happens to some people other than due to hydration issues.

Lungs

One of the main ingredients used in e-cig liquid solutions is propylene glycol (which is used as fog in concerts and theater) and glycerin (which is proven safe in foods).

“We’re putting things in e-cigs proven safe in foods, but it’s not the same as putting it into a vapor and inhaling it,” Foulds explains. “A Mars bar is safe to eat, but I wouldn’t want to inhale it. If something is safe as a food, it’s not highly harmful, but we don’t know what happens when you inhale it.”

There are concerns that nanoparticles from the vapor can be embedded in the lungs, causing inflammation and leaving the lungs vulnerable to infection. A study published in the journal PLOS this year found that the vapors damage the epithelial cells in the airways, leaving them vulnerable to infection.

“E-liquids without nicotine and with nicotine inhibit the lungs’ innate immunity, which helps it defend itself against infections,” study author, Qun Wu, MD, Ph.D, told Yahoo Health earlier this year.

The American Lung Association has called for more governmental oversight because “the reality is that without FDA regulation and review, we don’t know what is in e-cigarettes.”

Heart

The few studies that looked at e-cigarettes’ cardiovascular effects find that the ones containing nicotine raise heart rate and blood pressure. This is from the nicotine kick, which acts as a stimulant and prompts an adrenaline rush in the body. But studies have also found that e-cigarettes didn’t cause the type of disruptions in the body seen with tobacco smoking.

One small European study compared the heart functions of 20 young tobacco smokers versus 22 e-cigarette users seven minutes after using their products. The study conducted in Greece found none of the heart problems associated with tobacco cigarettes among e-cigarette users. Its lead researcher, Dr. Konstantinos Farsalinos, said in a statement: “This is an indication that although nicotine was present in the liquid used (11mg/ml), it is absorbed at a lower rate compared to regular cigarette smoking.”

The American Heart Association says there needs to be more research into this topic and called for rigorous examination of the “long-term impact of this new technology on public health, cardiovascular disease and stroke.”

Brain

When nicotine enters the brain, it releases a feeling of pleasure as dopamine levels increase.

Nicotine, while not considered a carcinogen, is still addictive and may “prime the brain to become addicted to other substances,” according to the National Institute on Drug Abuse.

One of the biggest concerns by anti-tobacco advocates is that e-cigarettes will get users hooked on nicotine and will serve as a gateway to tobacco use.

Your Baby

Nicotine can be detrimental to your baby if you’re pregnant. It affects the development of the baby’s lungs and brains, and can cause problems like preterm birth, low birth weight, and stillbirth in higher rates, research shows.

“For smokers of e-cigarettes, we know it’s going to increase premature birth [and] increase intensive care state,” Foulds says. “These are things that affect babies for life. Some believe e-cigs are completely safe — it’s not quite true.”

Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

Download (PDF, 401KB)

E-cigarettes just as dangerous

http://www.nst.com.my/node/97492

KUALA LUMPUR: Anti-tobacco advocates have called on the Health Ministry to ban e-cigarettes (e-cig) and e-liquids to prevent nicotine addiction among the younger generation.

Universiti Putra Malaysia’s senior consultant of public health medicine Professor Dr Lekhraj Rampal said the increase in e-cig users among adolescents and youth in Malaysia was a critical issue.

“A study overseas revealed that among adolescents, non-smokers who used e-cig showed more willingness to smoke cigarettes compared with those who had never used any tobacco product,” he told the New Straits Times.

He said a Dutch research showed that as well as nicotine, the potentially harmful substances in e-cigs included propylene glycol, glycerol, aldehydes, nitrosamines and metals, which when inhaled, could lead to irritation and damage to the respiratory tract, heart palpitations and increased risk of cancer.

He said propylene glycol was used to produce smoke, or vape, and the process of heating the substance at a voltage of more than five volts would produce formaldehyde, which was carcinogenic or cancer causing.

“Most vaporisers will use 10 to 12 volts to get more vape or smoke. The Dutch study showed that in some cases, the quantity of nicotine in the vapour was not in line with the breakdown on the packaging. In others, the concentrations of some substances were higher in the vapour than in the fluid.

“This substance will give the same or worse effect to people surrounding them. In addition, there are not many studies to prove that other volatile substances are not produced during vaping.”

Dr Lekhraj urged Malaysians not to jump to the conclusion that vaping was safer than smoking cigarettes, and wait for a directive from the World Health Organisation (WHO).

University Malaya Centre of Addiction Sciences addiction medicine specialist Associate Professor Dr Amer Siddiq Amer Nordin said e-cigs were not approved as quit-smoking aids in most countries.

“Without regulation at present, users are using these devices at their own risk. There is no control on quality of devices or more importantly the e-liquid used. Also, nicotine is a Group C Poison under the Poison Act 1952,” he said.

Malaysian Green Lung Association co-founder and president Ho Rhu Yann said if nicotine patches or gum were listed as Group C Poison, e-cigs should also be the same.

A Bernama report said a study on e-cigarette addiction conducted by the Institute of Respiratory Medicine (IPR) since 2013 was expected to be completed next year.

According to IPR’s senior medical consultant Professor Datuk Dr Abdul Razak Abdul Muttalif, the research, currently in the preliminary epidemiology stage, required more time to study.

“The e-cig issue is controversial, and there are pros and cons. We have to wait for the outcome and will also obtain information from WHO, which may take a long time, the latest by next year.”

Razak said e-cig smokers might experience acute effects, such as coughing and tiredness.

E-cigarettes and health — here’s what the evidence actually says

http://www.vox.com/2015/6/26/8832337/e-cigarette-health-fda-smoking-safety

Stepping into the health debate around electronic cigarettes is a messy and frustrating exercise. Depending on whom you ask, these devices are either the best technological solution to the smoking pandemic or the biggest looming threat to public health.

So to sort through the research and figure out whether e-cigarettes are actually safe, I read through more than 60 studies, articles, and reviews, and interviewed nine researchers and health experts about their work.

The bottom line

What we know:

E-cigarettes are probably better for you than conventional cigarettes, but worse for your health than not smoking or vaping at all.

What we don’t know:

What the long-term health effects of e-cigarettes are, whether they actually help people quit smoking, and how they’ll affect the use of other nicotine products.

What it means for you:

If you’re a chronic smoker, e-cigarettes could be a less destructive way to get your nicotine fix. If you don’t currently smoke at all, stay away from vaping; we still have no idea about its long-term health impact.

This is the first installment of Show Me the Evidence, where we go beyond the frenzy of daily headlines to take a deeper look at the state of science around the most pressing health questions of the day.

Here’s the bottom line: If you’re a chronic smoker looking for a nicotine fix and trying to decide between smoking and vaping, most experts would agree there’s a compelling case that e-cigarettes are less harmful.

But a nonsmoker, or an ex-smoker, should think twice before taking up the habit. Even if e-cigarettes are safer than regular cigarettes, that doesn’t mean they’re totally safe. At this point, we just don’t know. There have been no published long-term studies on the health of e-cigarette users, so the impact of vaping on the body over many years or decades is completely unknown. There are about 500 e-cigarette brands and more than 7,000 flavors on the market, and they work in different ways, delivering varying amounts of nicotine, toxins, and carcinogens. This means it’s hard to say anything concrete about the safety and health impact of all devices based on the research we do have.

Many of the studies out there are also limited in scope or flawed and biased by design. Adding to the uncertainty, in as many as one-third of e-cigarette studies, the authors have declared a conflict of interest, raising questions about bias.

This uncertainty has the research community divided. On one side, there are tobacco-control researchers who have spent their entire careers exposing the evils of the tobacco industry and view e-cigarettes in a negative light almost by default. There are also public health researchers who take a “zero-risk” approach and believe that, given the unknowns, these devices should not be tolerated. Many of these folks remember that it took decades for the tobacco industry to admit to the harms smoking caused, and that until very recently it falsely claimed “light” or “mild” cigarettes were a healthy alternative.

On the other side, there are researchers who view e-cigarettes more favorably for their harm-reduction potential. They think these devices could save the lives of millions of people. For now, researchers and industry representatives are either unlikely bedfellows in a harm-reduction game plan or at odds over the best way forward.

What is the state of the science on e-cigarettes?

The state of the science, in short, is crap. Many of the studies don’t pass basic tests of methodological rigor. There are only two published randomized control trials — considered the gold standard of scientific evidence — on e-cigarettes (this one and this one).

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61842-5/abstract

Worse, many of them may be hopelessly corrupted by industry money or bias.

Consider the conclusion of one of the most recent systematic reviews on e-cigarettes (which, unlike some of the others, was not supported by industry funding). This review, published in the American Journal of Preventive Medicine in 2014, looked at 76 of the best available studies on e-cigarettes:

“Due to many methodological problems, severe conflicts of interest, the relatively few and often small studies, the inconsistencies and contradictions in results, and the lack of long-term follow-up no firm conclusions can be drawn on the safety of [e-cigarettes].”

“Most studies were funded or otherwise supported/influenced by manufacturers of e-cigarettes”

The researchers also found that in 26 of the studies reviewed, the authors had declared a conflict of interest. They wrote: “Most studies were funded or otherwise upported/influenced by manufacturers of [e-cigarettes], but several authors had also been consultants for manufacturers of medicinal smoking cessation therapy.”

When I asked one of the review’s authors, Martin Døssing, what he made of the current evidence base on e-cigarettes, he said, “The literature is very poor.” He continued:

“The most worrying aspect of e-cigarettes is that we do not know the long-term health consequences of daily use. Will e-cigarette users come up with unsuspected diseases such as cancers in 10 or 20 years from the start of use 10 years ago? Substances known to be carcinogenic to man have been found in a few brands of e-cigarettes.”
One of the great complexities of research in this area is the fact that e-cigarettes types vary so widely. “What is an e-cigarette?” asks Judith Prochaska, a professor at Stanford’s prevention research center, rhetorically. The devices can hold a wide range of flavors and chemicals, they burn and deliver nicotine differently, and their technology is advancing fast. It’s hard to know whether findings of studies are generalizable at all.

But perhaps the biggest complication is that e-cigarettes are extremely new — and so the most important research hasn’t had time to be conducted. The first peer-reviewed studies only started emerging in 2010, meaning we are still far from the kind of scientific certainty that can give clues about the effects of e-cigarettes over decades.

How do e-cigarettes work?

These battery-powered devices deliver nicotine to the user through a vapor by heating a solution of propylene glycol or vegetable glycerin, flavoring, and other additives. Flavors range from butter rum to caramel macchiato to strawberry lemonade.

E-cigarettes have become increasingly popular in recent years. In 2015, the Centers for Disease Control and Prevention (CDC) reported that the use of e-cigarette devices among middle school and high school students tripled between 2013 and 2014. That means about 13 percent of students now use them — outstripping the number who smoke conventional cigarettes. By 2017, sales of e-cigarettes in the US are expected to surpass those of conventional cigarettes, reaching $10 billion. The three major tobacco companies, through their buying up of small e-cigarette companies, could share 75 percent of these profits over the next 10 years.

The major appeal of e-cigarettes is that they don’t contain tobacco and the exhaled vapor carries no harmful smoke, tar, or carbon monoxide. They also seem to have significantly fewer toxins and carcinogens than regular cigarettes.

Key question #1: How dangerous are e-cigarettes?

We don’t actually know. As an American Heart Association review on e-cigarettes states: “In general, the health effects of e-cigarettes have not been well studied, and the potential harm incurred by long-term use of these devices remains completely unknown.”

Key studies:

The science around e-cigarettes is still fairly new, but here are some of the key studies to date.

2010: Tobacco Control — “Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery”: The first peer-reviewed e-cigarette study, which showed that the devices can deliver nicotine and possibly reduce withdrawal from regular smoking.

2011: BMJ — “Electronic cigarettes as a method of tobacco control”: Makes the case that these devices can be used as a harm-reduction tool.

2013: The Lancet — “Electronic cigarettes for smoking cessation”: The first randomized trial of e-cigarettes, which showed the devices “were modestly effective” at helping smokers quit, and worked about as well as nicotine patches. (This study was done on early and now out-of-date devices, and had some serious limitations.)

2013: Tobacco Control — “Levels of selected carcinogens and toxicants in vapour from electronic cigarettes”: Researchers compared the levels of toxicants and carcinogens in e-cigarette vapor with tobacco cigarettes. They found they were nine to 450 times less prevalent than in conventional cigarette smoke.

2013: Psychopharmacology — “Acute electronic cigarette use: nicotine delivery and subjective effects in regular users”: This study found there are big individual differences in nicotine levels among e-cigarette users, even when they all vape on the same device.

2014: Tobacco Control — “Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation”: This study found that by January 2014, there were 466 brands and 7,764 unique flavors, making studying and regulating these devices a complex matter.

2015: Morbidity and Mortality Weekly Report — “Tobacco Use Among Middle and High School Students”: The use of e-cigarette devices among middle school and high school students tripled between 2013 and 2014. That means about 13 percent of students now use them — outstripping the number who smoke conventional cigarettes.

Based on the science so far, short-term exposure to e-cigarettes doesn’t appear to carry serious and immediate health effects. As the AHA points out, “The data on health effects to date, studied primarily in healthy people with short-term exposure, reveal little or no evidence of severe adverse events. Respiratory irritation and the bronchial constriction from a propylene glycol aerosol raise concerns about harm to people with asthma and chronic obstructive pulmonary disease, but one small study reports no harm but rather benefit when users quit smoking or smoke fewer cigarettes per day.”

Keep in mind, however, that the research here is still early, and this conclusion on e-cigarettes could change once tens of thousands of people — and not just dozens or hundreds — have been studied.

Bigger questions center on the toxicity of e-cigarette’s aerosol and liquids — and their potential long-term effects. Maciej Goniewicz, of Roswell Park Cancer Institute, is one of the leading researchers in this area. In one study, he looked at 12 brands of e-cigarettes and found that their vapors were mostly composed of nicotine and a nicotine solvent (propylene glycol or vegetable glycerin). Also, the levels of toxicants and carcinogens in e-cigarette vapor were nine to 450 times less prevalent than in conventional cigarette smoke.

Though propylene glycol and glycerin are generally considered safe substances, not a lot is known about the long-term effects of daily inhalation, Goniewicz says. There’s some evidence from theater settings — in which propylene glycol has been used to create fog — that suggests it can be a lung irritant. Goniewicz has also found toxic substances and cancer-causing compounds, such as formaldehyde and acetaldehyde, in e-cigarettes.

Reasons for concern have popped up elsewhere — though, again, nothing conclusive yet. Some research has shown that cells exposed to e-cigarette vapor showed similar genetic changes as cells exposed to conventional cigarette smoke — raising concerns that e-cigarettes could potentially lead to lung cancer.

One big problem here: E-cigarette products vary widely, making them tough to study. “Some had a higher presence of the toxicants, while other products have very low levels or even undetectable levels of toxicants,” Goniewicz said. What’s more, research shows that the heating process in e-cigarettes can change the composition of potentially harmful chemicals. “If the temperature goes too high, then there are more toxicants,” he warned.

Chris Bullen, an e-cigarette researcher and professor at the University of Auckland’s school of public health, noted that newer electronic cigarettes use a heating control mechanism that prevents “cooking” the e-liquid, and reduces the risk of generating harmful aldehydes. He cautioned about drawing conclusions from older studies that may be based on out-of-date technology. But he also added that there’s a lot of inconsistency in manufacturing quality: “Backyard operators” who make e-cigs may run the risk of contamination.

“Then there are the flavors,” he added. “Very little is known about what happens with these when heated and inhaled for weeks, months or years.”

Key question #2: Are e-cigarettes safer than regular cigarettes?

There are nearly 500 brands and more than 7,000 flavors of e-cigs. (Shutterstock)

Most researchers cautiously lean toward “yes” — despite the unknowns.

Because the immediate harms of e-cigarettes appear to be minimal compared with regular cigarettes, many researchers agree that there’s a compelling case to be made for e-cigarettes as a harm-reduction tool for heavy smokers, at least in the short term. (That was the conclusion of an August 2015 Public Health England review of the evidence, which estimated that e-cigarettes are “95 pecent less harmful” than regular cigarettes.)

The tougher question is how the long-term impacts of e-cigarettes compare to the long-term impacts of smoking. “It’s probably fair to say that a long-term e-cigarette user is not going to die from tobacco-caused disease,” says Thomas Eissenberg, co-director of the Center for the Study of Tobacco Products. “But it’s not clear whether they’ll die from an e-cigarette-caused disease and whether their rates of death will be less than, more than, or the same as the rates of death we see from tobacco-caused diseases.”

Key question #3: Do e-cigarettes actually help people stop smoking?

So far, two randomized studies (here and here) have looked into the question of quitting — and both found that e-cigarettes may indeed help smokers quit. Another lower-quality web-based survey came to the same conclusion.

But not everyone’s convinced. As a systematic review by the Cochrane Library noted: “The small number of trials, low event rates and wide confidence intervals around the estimates mean that our confidence in the result is rated ‘low.'” For example, there were weaknesses in the randomized trials. One trial compared e-cigarettes with nicotine patches for helping people quit. But participants had to go out and pick up the patches from the pharmacy, whereas e-cigs were delivered to their doorsteps — a difference that could have biased the results in favor of e-cigarettes.

Other evidence, meanwhile, suggests that e-cigarettes may not be so effective at helping people smoke fewer traditional cigarettes. A study published in JAMA Internal Medicine in 2014 concluded: “E-cigarette use by smokers was not followed by greater quitting, or reduction in consumption one year later.” Another 2015 study in the journal Addiction found that daily use of e-cigarettes seemed to be associated with an increase in the rate of attempts to quit smoking and less smoking, though not increased rates of quitting. These were both observational studies, so lower quality than the randomized trials.

So the evidence on quitting is still limited and has mixed results. And there are lots of harder questions that remain unanswered, as the American Thoracic Society has noted. Could e-cigarettes prolong the process of quitting? Could they make quitting less likely? For now, we don’t know.

Key question #4: Could e-cigarettes “re-normalize” smoking?

The use of e-cigarettes is growing among adolescents, while conventional cigarettes fall out of favor. (NEJM)

This is another concern some public health researchers have. After years of anti-smoking campaigns, rates of traditional cigarette smoking are falling. But what happens if e-cigarettes become more popular?

Could the availability of e-cigarettes entice former smokers to get hooked on nicotine again? Will e-cigarettes be a “gateway” device that carries people who would never have started smoking cigarettes into nicotine addiction? Or, relatedly: If more and more people use e-cigarettes, could that “re-normalize” regular cigarette use?

Those in favor of e-cigarettes say this renormalization is unlikely. They point to recent CDC data showing that the threefold increase in e-cigarette use among youth has been accompanied by a decline in the use of traditional cigarettes. There’s also some research that suggests nonsmokers who try e-cigs don’t progress to daily use — that it’s not a gateway drug.

“Maybe you get a chronic smoker to quit, but what about this next generation coming up?”
“Though we see experimentation,” said Lynne Dawkins, an experimental psychologist at the University of East London (who has received research funding from the industry), “we’re not seeing evidence of people using them regularly.”

On the flip side, researchers less enthusiastic about e-cigarettes note that the absolute use of nicotine products (such as hookah and cigars) has been trending up. There’s also this 2015 study in JAMA, which suggests students who use e-cigarettes are later more likely to report smoking combustible cigarettes compared with non-vapers. This observational study couldn’t prove that vaping caused the cigarette smoking, but while firm evidence on how e-cigarettes are changing behaviors is lacking, some researchers are concerned.

“Maybe you get a chronic smoker to quit,” said Stanford’s Prochaska, “but what about this next generation coming up who would not have picked up a combustible cigarette because it’s a dying behavior, but these devices are so trendy and they’re flavored and marketed to be really appealing to kids?”

Key question #5: Is nicotine, on its own, harmful?

Some researchers — especially those who view e-cigarettes more favorably — argue that nicotine in and of itself doesn’t harm people. The problem, they say, is the tobacco and other chemicals in combustible cigarettes.

The more staunch tobacco-control types argue that nicotine itself is dangerous and addictive and that it should be avoided. That puts e-cigarettes in a less favorable light.

The truth likely lies somewhere in between. As one review stated, “Nicotine is the addictive chemical in tobacco smoke, but its involvement in smoking-related harm (outside pregnancy) is very small, if any, compared to cigarette smoking.” Another systematic review pointed out that nicotine can have a variety of potential health effects, from raising one’s cardiovascular risk to causing birth defects in pregnant women.

There’s also some emerging science that suggests nicotine may confer benefits, from helping to treat Parkinson’s disease to enhancing attention and focus.

The other nicotine question has to do with whether e-cigs even deliver enough to satisfy smokers. We know from this Cochrane systematic review that if you want to help people quit smoking, you need to give them nicotine. Yet what’s clear right now is that not all e-cigarettes deliver the same amount of nicotine.

Some studies, such as this one in Nature, found that the nicotine delivery to the bloodstream from these devices varied, and was still much slower and lower than the concentrations that regular cigarettes give smokers. “Compared to smoking one tobacco cigarette,” the researchers wrote, “the [e-cigarette] devices and liquid used in this study delivered one-third to one-fourth the amount of nicotine after five minutes of use.”

Other more recent studies, like this one from 2015, suggest that at least some e-cigarette users may get nicotine doses similar to those from tobacco cigarettes.

Do these scientific debates matter for policy?

Yes. Right now, regulators are trying to figure out how to deal with e-cigarettes.

While some countries have banned the devices outright, the US federal government doesn’t regulate e-cigarettes, unless they’re being marketed for therapeutic purposes. This is because the Family Smoking Prevention and Tobacco Control Act of 2009 gave the Food and Drug Administration the power to regulate the tobacco industry, but e-cigarettes — along with other tobacco-related merchandise such as cigars and nicotine gels — were left out.

By April 2011, the FDA announced it was going to address this loophole. Then, in April 2014, the agency proposed a draft rule that will redefine e-cigarettes as “tobacco products.” Once finalized and enacted in another few years, e-cigarettes will be FDA-regulated under the Tobacco Control Act. Among other things, this would:

· Ban e-cigarette sales to minors

· Require health warning labels on e-cigarettes, which would warn of the possibility of addiction

· Prohibit vending machine sales of e-cigarettes except in places that don’t allow minors

· Require e-cigarette manufacturers to register a list of their products’ ingredients

· Require an FDA review of marketing plans

· Require FDA approval of any claims about e-cigarettes’ benefits, such as the claim that e-cigarettes can help people quit cigarettes

· Ban free samples of e-cigarettes

The FDA’s rules don’t include some restrictions that health advocates called for: They don’t halt online sales of e-cigarettes, prevent television and radio advertising, or ban the marketing of appealing flavors. They’re concerned because e-cigarette companies have already been targeting children and youth with appealing flavors, celebrity endorsements, and glitzy adverts.

Some public health officials and vaping advocates think that regulating e-cigarettes as tobacco products is overkill; after all, the devices don’t even hold tobacco. They also worry that if e-cigarettes are regulated too heavily or barred from the market, the public could miss out on a device that could have saved lives. Some experts also think heavy regulation could halt innovation, deterring manufacturers from creating more advanced devices with better nicotine delivery systems that could help reduce smoking.

As Peter Hajek, a professor at Queen Mary University of London, put it, “Regulators need to watch out for intended consequences of overzealous regulation, such as stifling such developments or making e-cigarettes more expensive and less attractive to smokers; and also avoid conveying a message that e-cigarettes are regulated as strictly [as] or even more strictly than cigarettes because they are as bad.”

FDA officials are conducting a scientific review of e-cigarettes and their effects. Until then, states, counties, and cities have been enacting their own e-cigarette regulations. The American Nonsmokers’ Rights Foundation tracks which lower levels of government have acted here.

E-cigarettes: an evidence update

Download (PDF, 2.07MB)

E-Cigarettes: A Disruptive Technology That Revolutionizes Our Field?

Download (PDF, 561KB)

Young people and e-cigarettes – what do the latest data tell us?

http://scienceblog.cancerresearchuk.org/2015/08/18/young-people-and-e-cigarettes-what-do-the-latest-data-tell-us/

Linda Bauld

In an article co-commissioned with The Conversation, Professor Linda Bauld – Director of the Institute for Social Marketing at the University of Stirling, and Cancer Research UK’s cancer prevention champion – looks at the latest evidence on e-cigarette use in young people.

Thanks to decades of action against tobacco, smoking rates among children and young people are in decline: far fewer teenagers are now taking up smoking than in the past.

In England, for example, just 3 percent of 11-15 year olds are regular smokers, with similar figures in Scotland and elsewhere in the UK. This is welcome news, and will play a significant role in protecting the adults of the future from the fourteen types of cancer linked to smoking, as well as other diseases such as heart disease and stroke.

Over the same period, we’ve also witnessed the advent of nicotine replacement as a means to help adult smokers quit. Reviewing these products back in 1991, Professor Michael Russell remarked that smokers ‘smoke for the nicotine, but they die from the tar’. In other words, it’s the many other toxic chemicals in combustible tobacco that cause disease and death – not nicotine.

Yet considerable public confusion exists about nicotine, with up to 90 percent of non-smokers, and 75 percent of smokers, believing it is harmful.

More recently, we’ve witnessed a rapid rise in the use of e-cigarettes, which has caused considerable debate and controversy – particularly surrounding their use and uptake among young people. This concern is probably partly caused by the confusion over the relative harmfulness of nicotine.

E-cigarettes commonly contain nicotine, as well as other substances including propylene glycol and flavourings. But unlike tobacco, they don’t expose people to many of the harmful chemicals found in tobacco. They’re widely available: the World Health Organisation recently estimated that half of the world’s population live in countries where e-cigarettes can be bought. And there’s a growing body of evidence that they can help adult smokers to stop using tobacco.

However, health professionals, policy makers and others are worried that e-cigarettes’ widespread availability might create a new generation of young nicotine addicts. If they were to take up tobacco smoking, this could undermine the great strides made against teenage smoking.

Is this a valid concern? What do the latest data tell us?

Emerging evidence

When my team at the University of Stirling first reviewed the studies on e-cigarette use in young people, early in 2014, we could only find nine published peer reviewed studies reporting prevalence of use in any country. Since then, more than 30 new studies have been published, from countries as diverse as Korea, France, Poland, Canada and Iceland. Most of these studies, particularly from larger countries like the USA, focus on a single region or school district.

The UK is an exception, and nationally representative cross-sectional data are available. What do they show?

Four representative surveys of UK teenagers were conducted in 2014, and while they focused on slightly different age groups, their findings were very consistent – a significant proportion of young people had tried electronic cigarettes at least once (8 percent in one survey in Great Britain, and 12 percent in a representative UK-wide survey, and in national surveys in Scotland and Wales).

The same survey for Great Britain had also been conducted previously in 2013, and in an analysis published just yesterday in Public Health, the proportion of young people who had tried e-cigarettes rose between the two surveys. But the proportion who regularly used e-cigarettes (i.e. more than once a month), was still very low in 2014 (from 0.4 per cent in Scotland to 2 percent in the UK survey), and concentrated in youth who also smoked.

Three of these surveys failed to find any young non-smokers who regularly used e-cigarettes
But what about among non-smokers?

Three of these surveys failed to find any young non-smokers who regularly used e-cigarettes, with the fourth – a survey of about 9,000 11-16 year olds in Wales – identifying just 54 participants who had never tried tobacco but who regularly used an e-cigarette.

What this all tells us is that, while young people are experimenting with e-cigarettes, and that the proportion who say they’ve tried them is rising, only very small numbers of young non-smokers are attracted to these products on any regular basis.

This, it’s worth remembering, is during a period when smoking rates among young people are continuing to fall, suggesting that – in the UK at least – there is no evidence yet that more young people are starting to smoke because of e-cigarettes.

But there’s an important caveat. The UK studies – like those in other countries – are cross-sectional surveys that merely provide a snapshot. They say nothing about longer-term trends, nor about changes in behaviour. For that, we need longitudinal studies, which follow the same group of people over time.

The US picture

New research – published today in the Journal of the American Medical Association – conducted in 10 high schools in Los Angeles, USA, provides the first example of a longitudinal study looking at e-cigarette and tobacco use.

It involved approximately 3,300 participants, who were 14 years old on average when they joined the study. They were followed up twice, after 6 and 12 months.

Among all participants, 7 percent had used an e-cigarette at least once in the past 30 days.

But once the researchers looked at the 2,530 who had never used tobacco at the start of the study, just 222 of them – 8.7 percent – said they’d ever tried an e-cigarette.

But were these young people more likely to then try smoking (either cigarettes, cigars or hookah pipes)?

The researchers found that those who said they’d tried an e-cigarette at the start of the study were also more likely to have tried smoking six months later (30.7 percent vs 8.1 per cent) and 12 months later (25.2 percent vs 9.3 percent).

The authors collected information on other factors that might put young people at risk of smoking (such as their socio-economic background) and adjusted for these – but still found the link.

So what to make of this finding? There are several caveats, as the authors make clear. This association doesn’t prove that e-cigarettes cause young people to take up smoking – it merely demonstrates a statistical link between the two. On top of this, the way e-cigarette and tobacco use were measured was very basic, only determining whether people had ‘ever’ or ‘recently’ used them – not whether this was regular or sustained use.

And importantly, the age group in the study had just moved to secondary school – a time of transition and trying new things.

The numbers that were the main focus of the analysis were also very small – just 222 non-smoking e-cigarette users.

So to find out more, future longitudinal studies are needed, that follow people up for longer, provide more information on how regularly they use e-cigarettes and tobacco, and also the types of products are used. And we need studies that provide evidence on the safety of e-cigarettes, and their role in smoking cessation.

And research is also needed to assess the impact of policy changes being introduced in a number of countries to regulate e-cigarettes, including measures to limit youth uptake.

For this reason research organisations such as Cancer Research UK are looking closely at the issue of e-cigarettes and funding a number of studies. Ongoing monitoring and research, including studies that involve the public and e-cigarette users, are important if we are to inform policy and practice.

Previous research has played a hugely valuable role in helping to protect young people from the disease and death that smoking causes. The place of e-cigarettes within this remains to be seen – but it may be important, and we need to study it.

Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence

Download (PDF, 584KB)

Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence

Download (PDF, 465KB)